ZA991482B - Lipopeptide antibiotic calcium salts, process for their preparations, and their use. - Google Patents

Lipopeptide antibiotic calcium salts, process for their preparations, and their use.

Info

Publication number
ZA991482B
ZA991482B ZA9901482A ZA991482A ZA991482B ZA 991482 B ZA991482 B ZA 991482B ZA 9901482 A ZA9901482 A ZA 9901482A ZA 991482 A ZA991482 A ZA 991482A ZA 991482 B ZA991482 B ZA 991482B
Authority
ZA
South Africa
Prior art keywords
preparations
calcium salts
lipopeptide antibiotic
antibiotic calcium
lipopeptide
Prior art date
Application number
ZA9901482A
Other languages
English (en)
Inventor
Lsszlo Vertesy
Werner Aretz
Heinrich Decker
Eberhard Ehlers
Michael Kurz
Frank Rainer Schmidt
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of ZA991482B publication Critical patent/ZA991482B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9901482A 1998-02-25 1999-02-24 Lipopeptide antibiotic calcium salts, process for their preparations, and their use. ZA991482B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19807972A DE19807972A1 (de) 1998-02-25 1998-02-25 Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ZA991482B true ZA991482B (en) 1999-08-25

Family

ID=7858906

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901482A ZA991482B (en) 1998-02-25 1999-02-24 Lipopeptide antibiotic calcium salts, process for their preparations, and their use.

Country Status (15)

Country Link
US (1) US6624143B1 (cg-RX-API-DMAC7.html)
EP (1) EP1068223B1 (cg-RX-API-DMAC7.html)
JP (1) JP4402833B2 (cg-RX-API-DMAC7.html)
AR (1) AR016713A1 (cg-RX-API-DMAC7.html)
AT (1) ATE223433T1 (cg-RX-API-DMAC7.html)
AU (1) AU2725299A (cg-RX-API-DMAC7.html)
CA (1) CA2322052C (cg-RX-API-DMAC7.html)
CO (1) CO4790157A1 (cg-RX-API-DMAC7.html)
DE (2) DE19807972A1 (cg-RX-API-DMAC7.html)
DK (1) DK1068223T3 (cg-RX-API-DMAC7.html)
ES (1) ES2182489T3 (cg-RX-API-DMAC7.html)
PT (1) PT1068223E (cg-RX-API-DMAC7.html)
TW (1) TW559623B (cg-RX-API-DMAC7.html)
WO (1) WO1999043700A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA991482B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1423656A (zh) 1999-12-15 2003-06-11 卡比斯特制药公司 作为抗菌剂的脂肽
BR0017026A (pt) 1999-12-15 2003-01-07 Cubist Pharm Inc Lipeptìdeos como agentes antibacterianos
IL150224A0 (en) 1999-12-15 2002-12-01 Cubist Pharm Inc Lipopeptides and pharmaceutical compositions containing the same
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
JP2004525108A (ja) † 2000-12-18 2004-08-19 キュービスト ファーマスーティカルズ インコーポレイテッド 精製リポペプチドの調製方法
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
US7125844B2 (en) 2002-01-03 2006-10-24 Migenix Inc. Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same
JP2007536200A (ja) 2003-07-17 2007-12-13 ミジェニックス インコーポレイテッド リポペプチド抗生物質誘導体の組成物およびその使用方法
US7795207B2 (en) 2005-11-21 2010-09-14 Harald Labischinski Lipopeptide compositions
DE102005056194A1 (de) * 2005-11-21 2007-07-12 Combinature Biopharm Ag Neue Lipopeptid Zusammensetzungen
GB0821540D0 (en) * 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
NZ594019A (en) * 2008-12-22 2013-08-30 Cubist Pharm Inc Novel antibacterial agents for the treatment of gram positive infections
CA2781666C (en) 2009-11-23 2017-02-21 Cubist Pharmaceuticals, Inc. Lipopeptide compositions and related methods
WO2017173932A1 (en) * 2016-04-08 2017-10-12 Versitech Limited Antibacterial cyclic lipopeptides
US11667674B2 (en) 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800162A (en) * 1987-04-01 1989-01-24 Sepracor, Inc. Method for resolution of steroisomers in multiphase and extractive membrane reactors
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5039789A (en) * 1988-04-11 1991-08-13 Eli Lilly And Company A54145 cyclic peptides
US6309440B1 (en) * 1998-08-25 2001-10-30 Thomas T. Yamashita Method and composition for promoting and controlling growth of plants
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
WO1998057923A1 (en) * 1997-06-18 1998-12-23 Fujisawa Pharmaceutical Co., Ltd. New production process

Also Published As

Publication number Publication date
TW559623B (en) 2003-11-01
DE19807972A1 (de) 1999-08-26
DE59902568D1 (de) 2002-10-10
AU2725299A (en) 1999-09-15
JP4402833B2 (ja) 2010-01-20
WO1999043700A1 (de) 1999-09-02
JP2002528382A (ja) 2002-09-03
PT1068223E (pt) 2003-01-31
US6624143B1 (en) 2003-09-23
ATE223433T1 (de) 2002-09-15
CA2322052C (en) 2009-09-29
EP1068223B1 (de) 2002-09-04
AR016713A1 (es) 2001-07-25
EP1068223A1 (de) 2001-01-17
DK1068223T3 (da) 2002-12-30
CA2322052A1 (en) 1999-09-02
ES2182489T3 (es) 2003-03-01
CO4790157A1 (es) 1999-05-31

Similar Documents

Publication Publication Date Title
HUP0102833A3 (en) Cyclosporins, process for preparation thereof and their use
MXPA02000977A (es) Sistema de sutura.
AU2430601A (en) Ion implantation ion source, system and method
EP1159605A4 (en) METHODS, DEVICES AND SYSTEMS FOR PROTEIN CHARACTERIZATION
HU9603495D0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents
ZA979220B (en) New oxadiazoles, processes for their preparation and their use as pharmaceutical compositions.
AU6200999A (en) Treatment for fabrics
ZA991273B (en) Amidinophenyl derivatives.
ZA200004956B (en) Vaccine composition.
ZA200104280B (en) Pharmaceutical combination preparations.
ZA976815B (en) Vaccine composition.
ZA200005510B (en) Pharmaceutical composition.
ZA979573B (en) (Alpha-aminophosphino) peptide derivatives, process for their preparation and their therapeutic applications.
DK1068223T3 (da) Lipopeptidantibiotika-calciumsalte, fremgangsmåde til deres fremstilling og anvendelse
ZA964778B (en) Methods for minimizing bone loss.
MXPA00007394A (es) Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas.
SI1141308T1 (sl) Streptokokni proteini skupine B in njihova uporaba
IL129168A (en) Sulfonamides, process for their preparation and process for their reduction
AU2002210439A1 (en) Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
IL154150A0 (en) Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
ZA200006750B (en) Prosthesis System.
GR3035834T3 (en) Benzoxazindione derivatives, process for their preparation and their use
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.
AU2795799A (en) Antibacterial drugs, methods for their design and methods for their use
HUP0102116A3 (en) Paroxetine ascorbate, process for its preparation and its pharmaceutical use